Activating transcription factor 4 (ATF4) is well known for its role in the endoplasmic reticulum (ER) stress response. ATF4 also transcriptionally induces multiple effectors that determine cell fate depending on cellular context. In addition, ATF4 can communicate both pro-apoptotic and pro-survival signals. How ATF4 mediates its prosurvival roles, however, requires further investigation. Here, we report that the CDK inhibitor p21 is a novel target gene of ATF4. We identified two ATF4-responsive elements, one of which directly binds ATF4, within the first intron of the p21 gene. Importantly, overexpression of p21 enhances cell survival following ER stress induction, while p21 knockdown increases cell death. These results suggest that p21 induction plays a vital role in the cellular response to ER stress and indicate that p21 is a prosurvival effector of ATF4.
The endoplasmic reticulum (ER) serves as an organelle for the folding and maturation of all secretory pathway proteins [1] [2] [3] . Accumulation of unfolded or misfolded proteins in the ER initiates a stress response termed the unfolded protein response (UPR). The UPR reduces ER stress by decreasing the translation and transcription of proteins and increasing ER chaperone levels, but if ER stress is not relieved, the UPR induces apoptosis. The UPR has been implicated in a variety of stress-related pathologies, including cancer.
In mammals, there are three ER transmembrane proteins that function as proximal effectors of the UPR: inositol-requiring enzyme 1; protein kinase RNA-like ER kinase (PERK); and activating transcription factor 6 (ATF6) [1] [2] [3] . Among these UPR signal transducers, PERK functions as a key transducer regulating fundamental cell functions [4] . Activated PERK phosphorylates eukaryotic translation initiator factor 2a (eIF2a), which leads to a reduction in general protein synthesis. In addition, eIF2a phosphorylation allows the translation of mRNAs containing small upstream open reading frames within their 5 0 -untranslated regions, such as ATF4 [5] . ATF4 can communicate both prosurvival and proapoptotic signals. ATF4 regulates the expression of genes involved in translation, amino acid metabolism, cellular redox state, and autophagy, which are useful for cellular adaptation to stress conditions; however, if the protein misfolding is not resolved, cell death signaling pathways are activated: ATF4 promotes the expression of proapoptotic factors such as C/EBP Abbreviations b-gal, b-galactosidase; ATF, activating transcription factor; CDKI, cyclin-dependent kinase inhibitor; CHOP, C/EBP homologous protein; eIF2a, eukaryotic translation initiator factor 2a; ER, endoplasmic reticulum; PERK, protein kinase RNA-like ER kinase; qPCR, quantitative PCR; SESN2, Sestrin2; siRNA, short interfering RNA; TG, thapsigargin; TM, tunicamycin; UPR, unfolded protein response.
homologous protein (CHOP), NOXA, and PUMA, leading to cell death [3] . Thus, while the specific activities of downstream effectors of ATF4-mediated proapoptotic signaling are well known, mechanistic details of how ATF4 mediates its prosurvival roles requires further investigation.
The cyclin-dependent kinase inhibitor (CDKI) p21 is an important downstream effector of the tumor-suppressor p53, mediating cell cycle arrest in response to various stimuli [6] . Although known for its growthinhibitory functions, p21 also acts as an inhibitor of apoptosis [7] . Therefore, p21 antiapoptotic activities could contribute to the cell's response to ER stress. Here, we report that CDKI p21 is a novel target gene of ATF4. We identified two ATF4-responsive elements, one of which directly binds ATF4, within the first intron of the p21 gene and found that overexpression of p21 enhanced cell survival following ER stress induction while gene silencing of p21 increased cell death. These results suggest that p21 induction plays a vital role in the cell's response to ER stress and indicate that p21 is a prosurvival effector of ATF4.
Materials and methods

Cell lines, plasmids, and transfections
The MCF7, HCT116, HaCaT, and TIG3 cells were maintained in Dulbecco's modified Eagle's medium (DMEM; Nacalai Tesque, Kyoto, Japan) supplemented with 4.5 gÁL À1 glucose, 10% FBS (Sigma, St. Louis, MO, USA), 100 UÁmL À1 of penicillin G, and 100 lgÁmL À1 of streptomycin. H1299 cells were cultured in Roswell Park Memorial Institute 1640 medium (Nacalai Tesque) containing 10% FBS and penicillin/streptomycin. Cells were grown in a 5% CO 2 atmosphere at 37°C. The original constructs encoding the human ATF4, CHOP, p53, C/EBPb, and b-galactosidase (b-gal) have been described previously [8, 9] . p21 intron-1 Luc (+1135 to +2234) and (+3543 to +5387) were kindly provided by D. Koinuma (University of Tokyo) [10] . p21 promoter Luc (À2300 to +8) was generated by ligating the human p21 promoter region [11] with pGL4.10. p21 intron-1 Luc (+90 to +1134) and (+2235 to +3542) were generated by ligating the human p21 intron-1 region with a modified pGL4.10 reporter plasmid driven by the adenovirus major late promoter. pcDNA3/ FLAG-p21 was constructed as follows: p21 was PCR-amplified using mRNA derived from MCF7 cells and inserted into pcDNA3/FLAG. All constructs were verified by sequencing.
For DNA transfection, plasmids were transiently transfected with Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA). MCF7 cells were also transfected by electroporation using Next-Generation Electroporator CUY21EDIT II (BEX, Tokyo, Japan): One million MCF7 cells were suspended in a 100 lL mixture of Opti-MEM and 10 lg plasmids. The mixture received two types of pulses, a poration pulse followed by driving pulses. The poration pulse was 125 V for 10 milliseconds (ms) with a positive polarity. The poration pulse was followed after an interval of 50 ms by five driving pulses of 20 V for 50 ms with a 50 ms interval between pulses. The driving pulses were of alternating positive and negative polarity and the condenser capacity was 940 lF. The transfection efficiency was~90%. For short interfering RNA (siRNA) transfection, siRNAs were transfected using Lipofectamine RNAi-MAX reagent (Invitrogen) according to the manufacturer's protocol. siRNA oligos targeting human ATF4 RNA and human CHOP RNA have been previously described [8] . The human p21 siRNA (sense: 5 0 -GAUGGAACUUCGA-CUUUGU-3 0 ) was purchased from Greiner [12] . Stealth RNAi TM siRNA Negative Control Med GC Duplex #2 was obtained from Invitrogen.
Luciferase assay
Cells were transfected with the luciferase reporter plasmid, expression plasmids, b-gal expression plasmid, and empty vector. The total amount of transfected DNA was the same in each experiment. Luciferase activity in cell lysates was measured. Luciferase activity was normalized against b-gal activity [13] .
RNA extraction and reverse transcription
Total RNA extractions were performed as previously described [14] . First-strand cDNA was synthesized with PrimeScript first-strand cDNA Synthesis Kit (TaKaRa Bio Inc., Shiga, Japan) as previously described [9, 13] .
Semiquantitative PCR and quantitative PCR (qPCR)
Semiquantitative PCR was performed as previously described [15] . PCR was performed using AmpliTaq Gold 360 Mater Mix (Applied Biosystems, Foster City, CA, USA) and a 2720 Thermal Cycler 2700 (Applied Biosystems). The following primer sequences were used: human p15, cation was stopped when the amplification was in the loglinear range and PCR products were separated by 1.5-2% agarose gel electrophoresis [9] . qPCR was performed as previously described [13] .
Immunoblotting
Immunoblotting was performed as previously described [16] . The following commercially available antibodies used were: anti-p21 (C-19; Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-p27 (Clone 57/Kip1/p27; BD Bioscience, Franklin Lakes, NJ, USA), anti-b-actin (AC-15; Sigma), anti-ATF4 (D4B8; Cell Signaling Technology, Beverly, MA, USA), anti-TRB3 (EPR3151Y; Abcam, Cambridge, UK), anti-PARP (#9542; Cell Signaling Technology), and anti-FLAG (M2; Sigma). Anti-CHOP polyclonal antibodies were previously described [17] .
Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation assay was performed as previously described [9] . The purified DNA was analyzed by semiquantitative PCR. The following primer sequences were used: human NOXA promoter (ATF4RE) 
Cell viability assay and apoptosis assay
Cell viability was determined using water-soluble tetrazolium WST-8 according to the manufacturer's instructions (Dojindo, Kumamoto, Japan). Cells were transfected as described above. Twenty-four hours after transfection, cells were trypsinized and reseeded at a concentration of 5 9 10 3 cells per well in a 96-well plate. After 24 h, the cells were treated with thapsigargin (TG) or tunicamycin (TM) for 24 h. The WST-8 reagent was added and the cells were incubated for 3 h at 37°C in a humidified atmosphere of 5% CO 2 . The absorbance at 450 nm of the medium was measured. The percentage of cell viability was normalized to the vehicle-treated cells. For apoptosis assay, both floating and attached cells were collected 24 h after TG treatment. Cells were then simultaneously stained with Annexin V-FITC and PI using the FITC Annexin V Apoptosis Detection Kit (BD Biosciences), according to the manufacturer's instructions.
Results
p21 is a novel target gene of ATF4
To characterize the role of ATF4 in cell cycle control in response to ER stress, we investigated whether ATF4 regulates the expression of cell cycle regulators. As shown in Fig. 1A ,B, overexpression of ATF4 resulted in upregulation of p21 mRNA and protein in H1299 cells. Because ATF4 can be activated by ER stress, we next investigated whether p21 is induced after treatment with TG, an inhibitor of ER Ca(2+)-ATPases. TG-induced p21 gene expression in MCF7 cells in a dose-and time-dependent manner (Fig. 1C,D) , and TG also upregulated p21 protein expression (Fig. 1E) . We also examined the p21 expression levels in MCF7 cells over a longer time course (0-48 h) after TG treatment. As shown in Fig. S1 , TG upregulated p21 expression, which peaked at 24 h and then slightly decreased, while maintaining a significant level until 48 h. TM, another ER stress inducer, also increased p21 mRNA in MCF7 cells, albeit only to a lesser extent than TG (Fig. 1F) . To investigate whether ATF4 is required for p21 induction upon ER stress, MCF7 cells were treated with siRNA to deplete ATF4. As shown in Fig. 1G , ATF4 knockdown reduced TRB3, an ER stress-inducible gene responsive to ATF4 [8] , induction after TG treatment, indicating that the transcriptional activity of ATF4 was attenuated. Similarly, ATF4 knockdown reduced the induction of p21 protein in MCF7 cells upon TG treatment (Fig. 1G) .
As p21 expression has been shown to be upregulated by p53, we inhibited p53 by siRNA in MCF7 cells and then subjected the cells to TG treatment. As shown in Fig. S2 , p53 knockdown reduced p21 induction after etoposide treatment; however, siRNA-mediated downregulation of p53 did not prevent TG-induced p21 upregulation. The induction of p21 expression was also observed in both HCT116 cells (containing wild-type p53) and HaCaT cells (containing mutant H179Y/ R282Q in p53) (Fig. 1H) . Moreover, TG-induced p21 upregulation occurred in TIG3 normal human diploid fibloblasts (Fig. 1I,J) . These results indicate that p21 induction upon ER stress is independent of p53 status and that ATF4 is required for p21 induction after ER stress.
The first intron of the p21 gene contains an ATF4-responsive element
To study p21 induction by ATF4, we initially performed luciferase assays using the p21 promoter reporter (À2300 to +8) ( Fig. 2A) . As shown in Fig. 2B, p53 increased the transactivation of the p21 promoter; however, ATF4 failed to activate the promoter activity of p21. Sequence analysis of the p21 locus disclosed a potential ATF4-binding site at +710 to +724 (GCGCTGAGGTCAGCG) in the first intron of p21. Consequently, we prepared a series of human p21 intron 1-luciferase reporter constructs ( Fig. 2A) and analyzed their responsiveness to ATF4 expression (Fig. 2C) . While the two fragments (+1135 to +2234, +2235 to +3542) showed no response to ATF4 expression, the reporter genes containing the regions +90 to +1134 and +3543 to +5387 were activated by ATF4 expression. Moreover, ChIP analysis showed that ATF4 could be detected in association with the putative ATF4 binding site in the p21 intron 1 region, similar to the NOXA promoter [18] (Fig. 2D) . These results suggest that ATF4 activates p21 gene expression through its binding in the first intron of the p21 gene.
While we could not identify the ATF4-binding site in the region +3543 to +5387, the sequence between +3821 and +4465 was shown to mediate enhancement of p21 expression by ATF4 (Fig. 2E,F) . Interestingly, when ATF4 and CHOP were coexpressed, the reporter activity was synergistically upregulated (Fig. 2G) . We also downregulated CHOP by siRNA in MCF7 cells and then subjected the cells to TG exposure. Indeed, CHOP knockdown as well as ATF4 or ATF4/CHOP knockdown potently inhibited p21 upregulation in MCF7 cells after TG treatment (Fig. S3) . Han et al. [19] have shown that ATF4 and CHOP interact to induce transcription of a common set of target genes under ER stress. Our results suggest that CHOP might be involved in p21 induction by cooperating with ATF4. Further investigation is needed to clarify this regulatory mechanism.
p21 enhanced cell survival following ER stress induction
As previously reported, exposure to TG resulted in massive apoptosis in MCF7 cells [20] , and ATF4 siRNA significantly reduced TG-induced cell death in MCF7 cells (Fig. 3A,B) . These results are not unexpected as it is well known that ATF4 can communicate both prosurvival and proapoptotic signals and that severe ER stress induces apoptosis. Notably, overexpressing p21 attenuated the cytotoxic effects of TG on MCF7 cells (Fig 3C,D) , indicating that p21 has potential antiapoptotic function even when the cell is severely stressed. More importantly, siRNA-mediated knockdown of p21 decreased cell viability of MCF7 cells after TG treatment (Fig. 3E,F) . Annexin V staining revealed that p21 knockdown enhanced apoptotic cell death in MCF7 cells after exposure to TG (Fig. 3G) . TM decreased the cell viability in MCF7 cells as well as TG, and p21 knockdown also decreased (Fig. 3H) . Furthermore, p21 knockdown results in decreased cell viability in other cell lines (HaCaT cells and TIG3 cells) after TG or TM treatment (Fig. 3I,J) , consistent with the data of Kiaris and colleagues, that p21 knockdown or knockout increased the sensitivity of TM, chemotherapeutic agents or hyperglycemia [21] [22] [23] [24] . Mihailidou et al. [22] have shown that p21 acts as an inhibitor of ER stress-associated tissue damage and that stimulation of p21 activity can be beneficial to the management of diabetes. Consistent with these findings, our results also support the idea that p21 acts as a prosurvival effector in response to ER stress.
Discussion
In this study, we demonstrated that ER stress regulation of p21 expression is dependent on ATF4. p21 is also induced by ectopic expression of ATF4. In addition, we have identified two ATF4-responsive elements within intron 1 of the p21 gene, one of which binds ATF4 directly. Finally, we demonstrated that p21 is a prosurvival effector of ATF4 (Fig 3K) . To date, it has been shown that the p21 expression can be regulated by several mechanisms under ER stress. Zhang et al. [25] have shown that ER stress triggers p53 activation to induce p21. Another study showed that ATF4 mediated increase in p21 mRNA during fasting [26] , which is consistent with our findings. Conversely, it has been demonstrated that p21 is downregulated during ER stress. Mlynarczyk and F ahraeus [24] have shown that p53Δ40 (p53/47) isoform prevents p53-induced p21 transcription during ER stress and that both isoforms repress p21 mRNA translation. Mihailidou et al. [21] [22] [23] have also shown that CHOP has been shown to suppress p21 expression under ER stress. In contrast, our results suggest that CHOP might be involved in p21 induction by cooperating with ATF4 ( Fig. 2G and Fig. S3 ). This is not unexpected because it is possible that CHOP regulates its target genes in other cell types or contexts. For example, C/EBPa and C/ EBPb have been shown to stimulate the transcription of p21 [27] [28] [29] . Consistent with this notion, CHOP competes with C/EBPa to inhibit p21 transcription [22] . On the other hand, we and others have reported that CHOP and ATF4 cooperate to activate their target genes under ER stress [8, 19] . Therefore, CHOP can act as a multiple regulator of p21 expression. Further studies are necessary to clarify these concerns.
It has been widely accepted that mild ER stress is an adaptive, prosurvival response aiming at resolving the stress associated with accumulation of unfolded or misfolded proteins and restoring homeostasis, but that prolonged ER stress can lead to induction of cell death [3, 30] . ATF4 is an important factor in determining cellular fate in response to ER stress. It is well known that induction of ATF4 in response to ER stress induces apoptosis [18] (also see Fig. 3A,B) . However, ATF4 also induces expression of prosurvival proteins (Fig. 3K) . Sestrin2 (SESN2), a member of the stressinducible Sestrin family, has been shown to be transcriptionally upregulated by ATF4 during ER stress and amino acid deprivation [31, 32] . SESN2 induction in response to ER stress is responsible for mTORC1 inactivation and contributes to cell survival. ATF4 has also been shown to induce anti-apoptotic Mcl-1 after proteasome inhibitor bortezomib treatment [33] . Our study demonstrated the pro-survival role of p21 after ER stress. The marked increase in cell death upon exposure to TG in p21 knockdown cells (Fig. 3F ) strongly suggests that these pathways are vital in maintaining tissue integrity. In addition, while the full spectrum of the cell's responses to ATF4-mediated induction of p21 expression requires further investigation, p21 is a well known inhibitor of the cell cycle [6] and it is likely that inhibition of the cell cycle in cells responding to ER stress is protective of that cell's genomic integrity. Considering these factors, we suggest that aberrant regulation of ATF4 prosurvival and proapoptotic pathways may be important therapeutic targets relevant to a variety of diseases including cancer.
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